<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Lytton Leaves VC Firm for Biogen</title>
	<atom:link href="http://www.xconomy.com/boston/2009/02/23/lytton-leaves-vc-firm-for-biogen/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.xconomy.com/boston/2009/02/23/lytton-leaves-vc-firm-for-biogen/</link>
	<description>Business + Technology in the Exponential Economy</description>
	<lastBuildDate>Sat, 11 Feb 2012 01:49:51 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.0.4</generator>
	<item>
		<title>By: Antibody Industry Week in Review &#124; 2.27.09 — The Antibody Blog</title>
		<link>http://www.xconomy.com/boston/2009/02/23/lytton-leaves-vc-firm-for-biogen/comment-page-1/#comment-47793</link>
		<dc:creator>Antibody Industry Week in Review &#124; 2.27.09 — The Antibody Blog</dc:creator>
		<pubDate>Fri, 27 Feb 2009 11:18:58 +0000</pubDate>
		<guid isPermaLink="false">http://www.xconomy.com/?p=13694#comment-47793</guid>
		<description>[...] Lytton joined Biogen Idec as executive vice president of business development.  Lytton was previously a general [...]</description>
		<content:encoded><![CDATA[<p>[...] Lytton joined Biogen Idec as executive vice president of business development.  Lytton was previously a general [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

